1
0
0
News
BioVersys and Enamine Announce Extension of elEconomista.es
www.eleconomista.es
Dr. Marcel Tigges, Co-Founder and CSO at BioVersys, added: “We have established a network of partnerships with key players in the areas where we need ... › empresas-finanzas › noticias
BioVersys AG Series A successful closu - SECA
www.seca.ch
Marc Gitzinger (CEO) and Dr. Marcel Tigges (CSO). With the funds raised, BioVersys plans to conclude its preclinical work with its first lead compounds and ... › mobile › news › detail › News
BioVersys and Enamine Extend Collaboration
www.technologynetworks.com
Dec 2, — Dr. Marcel Tigges, Co-Founder and CSO at BioVersys, added: “We have established a network of partnerships with key players in the areas ... › ... › News
Detail - EPFLCareer
epflcareer.ch
Marcel Tigges Associate Director In order to attend a Career live stream, you will be asked to create an account with CareerFairy, our partner for this ... › events › detail
Telephone & Addresses
A tunable synthetic mammalian oscillator - IDEAS/RePEc
ideas.repec.org
by M Tigges · · Cited by 714 — Marcel Tigges & Tatiana T. Marquez-Lago & Jörg Stelling & Martin Fussenegger, "A tunable synthetic mammalian oscillator," Nature, Nature, vol. › nat › nature
Network Profiles
LinkedIn: Marcel Tigges | LinkedIn
Marcel Tigges' berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Marcel Tigges dabei hilft, ...
Interests
TOP 100 Startups: HouseTrip vor BioVersys und Abionic
www.startwerk.ch
Sep 18, — Marcel Tigges, BioVersys. Top 100 Startups: Die Halle der Härterei auf dem Maag-Areal war bis auf den letzten Platz besetzt. ›
BioVersys and Enamine Announce Extension Business Wire
www.businesswire.com
Dec 2, — Dr. Marcel Tigges, Co-Founder and CSO at BioVersys, added: “We have established a network of partnerships with key players in the areas ... › news › home › BioVer...
Samenvatting: Enamine en BioVersys verlengen samenwerking ...
www.businesswire.com
Dr. Marcel Tigges, + Chief Science Officer of. Media enquiries. Zyme Communications › home
BioVersys: Kampf den Bakterien » startwerk.ch
www.startwerk.ch
Von der Hightech-Forschung an der ETH zum hoffnungsvollen Startup: BioVersys entwickeln Stoffe zur Umgehung von Antibiotikaresistenzen.
Business Profiles
Marcel TIGGES | Scientist | J&J | Drug Development Operations
www.researchgate.net
› Johnson & Johnson
patentbuddy: Marcel Tigges
BIOVERSYS AG, Bettingen, CH
Education
Bachelor- arbeiten | ZHAW Life Sciences
www.zhaw.ch
Dr. Marcel Tigges. Aus vertraulichen Gründen darf die Zusammen fassung nicht veröffentlicht werden. Page Im Rahmen der Bachelorarbeit wurde die. › bachelor › biotechnologie
Organic chemistry - ZHAW
pd.zhaw.ch
Dr Marc Gitzinger; Dr Marcel Tigges,. BioVersys AG, Basel, Switzerland. Professor Dr Martin Fussenegger, ETHZ,. Basel, Switzerland. Professor Dr Daniel ...
Bad news
findagrave: Tigges, Marcella Julia "Sally" Kennebeck
, Carroll (Carroll County, Iowa)
Books & Literature
Marcel Tigges | ETH Zurich | 948 Citations | Related Authors
typeset.io
› authors › marcel-tigges-ig8gb1hwut
Related Documents
Anti Microbial Resistance (AMR) - SlideShare
www.slideshare.net
Adjuvant strategies for potentiation of antibiotics to overcome antimicrobial resistance (Michel Pieren and Marcel Tigges, Current Opinion in Pharmacology ... › amr
Small Molecule Downregulation of PmrAB Reverses Lipid A ...
pubs.acs.org
by TL Harris · · Cited by 77 — ... Valentina Lucchini, Birgit Schellhorn, Michel Pieren, Sergio Lociuro, Marc Gitzinger, Marcel Tigges, Dirk Bumann, Christian Kemmer, . › doi › abs
Chemoproteomic characterization of covalent target ...
mediatum.ub.tum.de
by LT Dittus · — Reference: Dr. Marcel Tigges (). September –. October Baden-Wuerttemberg Cooperative State University in cooperation with. › download
pdf, 4.8mb - ETH - Finanzen und Controlling - ETH Zürich
www.yumpu.com
29 Apr — Marc Gitzinger und Dr. Marcel Tigges, D-BSSE, Preisträger. venture kick, St. Gallen, Schweiz. Dr. Wulf Glatz, D-MAVT, Swiss Electric ... › view
Scientific Publications
BioVersys Works to Bring Antibiotic Resistance to PubMed
pubmed.ncbi.nlm.nih.gov
by M Tigges · — Authors. Marcel Tigges , Marc Gitzinger. Affiliations. 1 BioVersys AGc/o Technologiepark, CH Basel, ... › ...
metabolite phloretin - jstor
www.jstor.org
by M Gitzinger · · Cited by 112 — Schoenberg, Marcel Tigges, and William Bacchus for critical comments on the manuscript. This work was supported by the Swiss National Science Founda-. › stable
Patents Assigned to BioVersys AG - Justia Patents Search
patents.justia.com
Inventors: Peter Schneider, Rainer Riedl, Marcel Tigges, Marc Gitzinger, Michel Pieren, Assaf Levi, Mark Sephton, Birgit Schellhorn, Patrik Zueger, Michael ...
Metabolic Engineering | Vol 12, Issue 1, Pages (January 2010) |...
www.sciencedirect.com
The online version of Metabolic Engineering at ScienceDirect.com, the world's leading platform for high quality peer-reviewed full-text journals.
Publications
(PDF) Dissecting Colistin Resistance Mechanisms in
research.amanote.com
Jul 16, — ... Marcus Tötzl Valentina Lucchini Birgit Schellhorn Michel Pieren Sergio Lociuro Marc Gitzinger Marcel Tigges Dirk Bumann Christian Kemmer ... › publication › dissecting-...
Rational design of a small molecule-responsive BioMedSearchwww.biomedsearch.com/attachments gkr829.pdf
www.biomedsearch.com
David Ausla¨nder, Markus Wieland, Simon Ausla¨nder, Marcel Tigges and. Martin Fussenegger*. ETH Zurich, Department of Biosystems ...
Marcel Tigges's Research on Hormones | CureHunter
www.curehunter.com
Marcel Tigges Selected Research. Hormones , Dyrk1A potentiates steroid hormone-induced transcription via the chromatin remodeling factor Arip4.
Marcel Tigges's Research on Down Syndrome (Down's Syndrome) |...
www.curehunter.com
Marcel Tigges Selected Research. Down Syndrome (Down's Syndrome) , Dyrk1A potentiates steroid hormone-induced transcription via the chromatin ...
Reports & Statements
Twitter Posts: NanoTemper on Twitter: "Sign up for the @GENbio webinar to learn ...
webinar to learn how Dr. Marcel Tigges from. @JanssenGlobal. tackles production challenges that researchers face when working on large molecule process ... › NanoTemper › status
Synthetic systems biology : Web focus - Nature
www.nature.com
Marcel Tigges, Tatiana T. Marquez-Lago, Jörg Stelling & Martin Fussenegger. Nature 457, 309–312 (15 January 2009) doi : nature › collections › sxwspzqpyk
BIOTECH IN EUROPE INVESTOR FORUM - DocPlayer.net
docplayer.net
Dr. Marc Gitzinger, CEO Dr. Marcel Tigges, CSO Dr. Peter Sennhenn, VP Medicinal Chemistry. 66 CONTACT Tommi Lehtonen CEO Tukholmankatu 8 Helsinki Finland ... › Biotech-in-europe-in...
BioVersys works to bring antinbiotic resistance to an end
blog.sciencenet.cn
Dec 18, — Bioversys©MartinHeimann.jpg. Marcel Tigges and Marc Gitzinger from BioVersys ©Martin heimann. BioVersys, venture kick winner and ... › blog
Miscellaneous
WO A1 - Composition for treatment of pathogens ...
patents.google.com
Application number: PCT/EP ; Other languages: French (fr); Inventor: Peter Schneider: Rainer Riedl: Marcel Tigges: Marc Gitzinger: Michel Pieren ... › patent
BioVersys and Enamine Announce Extension of Drug Discovery ...
kommunikasjon.ntb.no
Dr. Marcel Tigges, Co-Founder and CSO at BioVersys, added: “We have established a network of partnerships with key players in the areas where we need ... › pressemelding › biover...
BioVersys holt Finanzierung von CHF 2.5 Mio. - Ifj.ch
www.ifj.ch
Das Team um die Gründer Dr. Marc Gitzinger (CEO) und Dr. Marcel Tigges (CSO) freut sich um den Zuwachs der erfahrenen Investoren und schaut nun ... › BioVersys-holt-F...
GenBio's Competitors, Revenue, Number of Employees, Funding ...
www.owler.com
Sign up for the GENbio webinar to learn how Dr. Marcel Tigges from JanssenGlobal tackles production challenges that researchers face when working on large ... › company › genbio
Improving Large Molecule Production NanoTemper
resources.nanotempertech.com
In this webinar, we will learn from Dr. Marcel Tigges about some of the production challenges faced by researchers working on large molecule process ... › webinars › imp...
Untitled
journals.plos.org
... Dr. Marcel Tigges, personal communication). Could the imperturbability of circadian clocks even when buffeted by the gusts of metabolic changes provoked ... › plosbiology › article › file › j...
biotechnet Switzerland - Swiss Biotech Association - expydoc.com
expydoc.com
At the Department of Biosystems Science and Engineering of the ETH in Basle, Dr. Marc Gitzinger and Dr. Marcel Tigges have been reflecting about how to ... › doc › biotechnet-switzerland---s...
BioVersys AG receives the Swiss Technology Award
www.venturekick.ch
4 Nov — ... overcoming the rising threat of drug resistant bacterial infections,» stated Dr. Marc Gitzinger (CEO) and Dr. Marcel Tigges (CSO). › ...
A modular degron library for synthetic circuits in mammalian ...
research-explorer.app.ist.ac.at
by H Chassin · · Cited by 37 — Chassin, Hélène, Marius Müller, Marcel Tigges, Leo Scheller, Moritz Lang, and Martin Fussenegger. “A Modular Degron Library for Synthetic ... › record
A synchronized quorum of genetic clocks.
primo.utb.edu.co
A tunable synthetic mammalian oscillator. Marcel Tigges Nature.2009, Vol. 457(7227), p Artículo sugerido por. Más sugerencias. › openurl
A tunable synthetic mammalian oscillator - Document - Gale
go.gale.com
by M Tigges · · Cited by 712 — Gale OneFile includes A tunable synthetic mammalian oscillator by Marcel Tigges, Tatiana T. Marquez-Lago,. Click to explore. › i.do
A tunable synthetic mammalian oscillator - Semantic Scholar
www.semanticscholar.org
Marcel Tigges, T. Marquez-Lago, +1 author. M. Fussenegger; Published 15 January 2009; Biology; Nature. Autonomous and self-sustained oscillator circuits ... › paper › A-tunable-synt...
BioVersys AG And SARomics Biostructures Join Efforts To ...
www.biospace.com
Feb 5, — explained Marcel Tigges, CSO at BioVersys. “We are excited to collaborate with BioVersys on this potentially game-changing approach that ... › article › releases › bioversy...
BioVersys AG, Basel, Schweiz - North Data
www.northdata.de
Name · Nicht mehr Gesellschafter: BioVersys GmbH · Mitglied des Verwaltungsrats: Martin Fussenegger, Marcel Tigges · Nicht mehr Geschäftsführer (1 Person) ... › CHE
BioVersys closes a CHF million financing round to ...
www.venturelab.swiss
Jun 8, — The antibiotic resistance of pathogens is a ticking timebomb, one that biochemists Marc Gitzinger and Marcel Tigges want to defuse. Jun 13, — The antibiotic resistance of pathogens is a ticking timebomb, one that biochemists Marc Gitzinger and Marcel Tigges want to defuse. › BioVersys-closes-a-CHF... › venture-kick-winner-Bio...
BioVersys et Enamine annoncent la prolongation de leur BFMTV
www.bfmtv.com
Nous sommes ravis de collaborer avec BioVersys, une société biopharmaceutique innovante dans le domaine de la résistance bactérienne. » Le Dr Marcel Tigges, ... › patrimoine
Connected Papers | Find and explore academic papers
www.connectedpapers.com
Feb 9, — M. Pieren, Marcel Tigges , Current opinion in pharmacology. Terpenes from essential oils and hydrolate of Teucrium alopecurus triggered ... › main
Controlling transgene expression in subcutaneous implants ...
www.pnas.org
by M Gitzinger · · Cited by 112 — ... and Marcia Schoenberg, Marcel Tigges, and William Bacchus for critical comments on the manuscript. This work was supported by the Swiss National Science ... › doi › abs › p...
Degrons in cancer - OUCI
ouci.dntb.gov.ua
by B Mészáros · Cited by 88 — Hélène Chassin, Marius Müller, Marcel Tigges, Leo Scheller, Moritz Lang, Martin Fussenegger. https://doi.org s · Full text. › works
Related search requests for Dr. Marcel Tigges
| Jörg Stelling Peter Schneider Michel Pieren | Birgit Schellhorn Moritz Lang Martin Fussenegger | Rainer Riedl |
People Forename "Marcel" (15928) Name "Tigges" (338) |
sorted by relevance / date